Inhibrx Biosciences, Inc. (INBX)
Nasdaq · Biological Products, (No Diagnostic Substances) · Inc. DE
What they're doing
Between 2026-06-21 and 2026-09-19, public records show 11 signals for Inhibrx Biosciences, Inc.. Most notable: 2026-09-08: 3 insiders bought $3.5M within 14 days; 2026-09-08: Lappe Mark (director) bought $1.1M of stock; 2026-09-08: Lappe Mark (director) bought $665k of stock. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.
Generated 2026-09-19 from public records.
Signals, last 12 months
- Insider purchaseKayyem Jon Faiz (director) bought $500k of stock
- Insider buying cluster3 insiders bought $3.5M within 14 days
- Insider purchaseLappe Mark (director) bought $1.1M of stock
- Insider purchaseLappe Mark (director) bought $665k of stock
- Insider purchaseKayyem Jon Faiz (director) bought $568k of stock
- Insider purchaseLappe Mark (director) bought $585k of stock
- Insider purchaseFORSYTH DOUGLAS (director) bought $287k of stock
- Insider purchaseLappe Mark (director) bought $136k of stock
- Insider purchaseLappe Mark (director) bought $118k of stock
- Insider purchaseLappe Mark (director) bought $54k of stock
- Material 8-K filingFiled 8-K disclosing material agreement
- Large insider saleVIKING GLOBAL INVESTORS LP; Viking Global Opportunities Parent GP LLC; Viking Global Opportunities GP LLC; Viking Global Opportunities Portfolio GP LLC; Viking Global Opportunities Illiquid Investments Sub-Master LP; HALVORSEN OLE ANDREAS; Ott David C.; Shabet Rose Sharon (ten_percent_owner) sold $10.0M of stock
- Large insider saleViking Global Opportunities Parent GP LLC (ten_percent_owner) sold $10.0M of stock
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-09-16 | Kayyem Jon Faiz | director | P | 5,000 | 100 | $500,000 |
| 2026-09-15 | MANHARD KIMBERLY | director | S | 500 | 105.05 | $52,525 |
| 2026-09-14 | MANHARD KIMBERLY | director | S | 500 | 110.26 | $55,130 |
| 2026-09-11 | MANHARD KIMBERLY | director | S | 500 | 111.78 | $55,888 |
| 2026-09-09 | MANHARD KIMBERLY | director | S | 500 | 115.8 | $57,898 |
| 2026-09-08 | MANHARD KIMBERLY | director | S | 500 | 115.14 | $57,570 |
| 2026-09-08 | Lappe Mark | director | P | 9,681 | 112.28 | $1,087,001 |
| 2026-09-08 | Lappe Mark | director | P | 1,219 | 111.88 | $136,382 |
| 2026-09-08 | Kayyem Jon Faiz | director | P | 5,000 | 113.52 | $567,580 |
| 2026-09-08 | FORSYTH DOUGLAS | director | P | 2,500 | 114.65 | $286,617 |
| 2026-09-08 | Lappe Mark | director | P | 5,895 | 99.29 | $585,343 |
| 2026-09-08 | Lappe Mark | director | P | 6,605 | 100.64 | $664,719 |
| 2026-09-08 | Lappe Mark | director | P | 1,100 | 107.12 | $117,836 |
| 2026-09-08 | Lappe Mark | director | P | 500 | 108.24 | $54,118 |
| 2025-10-07 | Viking Global Opportunities Parent GP LLC | ten percent owner | S | 16,315 | 32.25 | $526,159 |
| 2025-10-07 | Viking Global Opportunities Parent GP LLC | ten percent owner | S | 308,643 | 32.25 | $9,953,737 |
| 2025-10-07 | Viking Global Opportunities Parent GP LLC | ten percent owner | S | 25,042 | 32.25 | $807,605 |
| 2025-10-07 | VIKING GLOBAL INVESTORS LP; Viking Global Opportunities Parent GP LLC; Viking Global Opportunities GP LLC; Viking Global Opportunities Portfolio GP LLC; Viking Global Opportunities Illiquid Investments Sub-Master LP; HALVORSEN OLE ANDREAS; Ott David C.; Shabet Rose Sharon | ten percent owner | S | 308,643 | 32.25 | $9,953,737 |
| 2025-10-07 | VIKING GLOBAL INVESTORS LP; Viking Global Opportunities Parent GP LLC; Viking Global Opportunities GP LLC; Viking Global Opportunities Portfolio GP LLC; Viking Global Opportunities Illiquid Investments Sub-Master LP; HALVORSEN OLE ANDREAS; Ott David C.; Shabet Rose Sharon | ten percent owner | S | 16,315 | 32.25 | $526,159 |
| 2025-10-07 | VIKING GLOBAL INVESTORS LP; Viking Global Opportunities Parent GP LLC; Viking Global Opportunities GP LLC; Viking Global Opportunities Portfolio GP LLC; Viking Global Opportunities Illiquid Investments Sub-Master LP; HALVORSEN OLE ANDREAS; Ott David C.; Shabet Rose Sharon | ten percent owner | S | 25,042 | 32.25 | $807,605 |
| 2025-03-27 | Kayyem Jon Faiz | director | G | 90,000 | 0 | $0 |
| 2025-03-27 | Kayyem Jon Faiz | director | G | 90,000 | 0 | $0 |
| 2024-12-16 | Kayyem Jon Faiz | director | G | 250,000 | 0 | $0 |
| 2024-12-16 | Kayyem Jon Faiz | director | G | 500,000 | 0 | $0 |
| 2024-12-16 | Kayyem Jon Faiz | director | G | 250,000 | 0 | $0 |
| 2024-12-16 | Kayyem Jon Faiz | director | G | 500,000 | 0 | $0 |
| 2024-12-16 | Kayyem Jon Faiz | director | G | 250,000 | 0 | $0 |
| 2024-12-16 | Kayyem Jon Faiz | director | G | 250,000 | 0 | $0 |
| 2024-12-06 | Kayyem Jon Faiz | director | G | 52,000 | 0 | $0 |
| 2024-12-06 | Kayyem Jon Faiz | director | G | 52,000 | 0 | $0 |
| 2024-11-20 | Kayyem Jon Faiz | director | P | 18,750 | 14.19 | $266,063 |
| 2024-11-20 | Kayyem Jon Faiz | director | P | 18,750 | 14.19 | $266,063 |
| 2024-11-20 | Kayyem Jon Faiz | director | P | 18,750 | 14.19 | $266,102 |
| 2024-11-20 | Kayyem Jon Faiz | director | P | 18,750 | 14.19 | $266,102 |
| 2024-11-19 | Kayyem Jon Faiz | director | P | 34,843 | 14.23 | $495,816 |
| 2024-11-19 | Kayyem Jon Faiz | director | P | 34,843 | 14.23 | $495,816 |
| 2024-11-19 | Kayyem Jon Faiz | director | P | 34,843 | 14.23 | $495,708 |
| 2024-11-19 | Kayyem Jon Faiz | director | P | 34,843 | 14.23 | $495,708 |
| 2024-10-03 | Vuori Kristiina MD | director | P | 6,667 | 15 | $100,005 |
| 2024-10-03 | Vuori Kristiina MD | director | P | 6,667 | 15 | $100,005 |
| 2024-09-16 | Lappe Mark | director | P | 13,037 | 17.13 | $223,324 |
| 2024-09-16 | Lappe Mark | director | P | 13,037 | 17.13 | $223,324 |
| 2024-09-12 | Lappe Mark | director | P | 26,963 | 15.05 | $405,793 |
| 2024-09-12 | Lappe Mark | director | P | 26,963 | 15.05 | $405,793 |
| 2024-09-11 | Vuori Kristiina MD | director | P | 6,457 | 15.07 | $97,307 |
| 2024-09-11 | Vuori Kristiina MD | director | P | 6,457 | 15.07 | $97,307 |
| 2024-09-10 | Vuori Kristiina MD | director | P | 179 | 15 | $2,685 |
| 2024-09-10 | Lappe Mark | director | P | 8,500 | 15.19 | $129,115 |
| 2024-09-10 | Vuori Kristiina MD | director | P | 179 | 15 | $2,685 |
| 2024-09-10 | Lappe Mark | director | P | 8,500 | 15.19 | $129,115 |
Federal contracts
No federal contract actions on record for this recipient mapping.
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
No Wikipedia pageview data linked to this company.